Amarin Corp Plc (AMRN)

[HDGabor]

k-

baseline -> end

ANCHOR / EPA -> EPA / AA -> AA / AA:EPA -> AA:EPA / EPA:AA -> EPA:AA

4g / 19.57 -> 144.68 / 281.40 -> 222.80 / 14.38 -> 1.54 / 0.07 -> 0.65
2g / 26.58 -> 89.26 / 301.20 -> 266.70 / 11.33 -> 2.99 / 0.09 -> 0.33
placebo / 24.29 -> 24.39 / 307.60 -> 328.40 / 12.66 -> 13.46 / 0.08 -> 0.07

JELIS / EPA -> EPA / AA -> AA / AA:EPA -> AA:EPA / EPA:AA -> EPA:AA

placebo / 93.00 -> 95.00 / 162.00 -> 170.00 / 1.74 -> 1.79 / 0.57 -> 0.56
1.8g / 97.00 -> 166.00 / 162.00 -> 153.00 / 1.67 -> 0.92 / 0.60 -> 1.08

Best,
G

ps.: I have these data … I did not check (now) what type they are.


UPDATE: Some additional data

EPA Plasma Concentrations (µg/g)

Baseline Mean (SD) / End of Treatment Mean (SD)
AMR 101 4 g/day (n=43): 19.57 (6.410) / 144.68 (56.464)
AMR 101 2 g/day (n=50): 26.58 (13.081) / 89.26 (39.682)
Placebo (n=51): 24.29 (29.025) / 24.39 (25.073)

EPA RBC Concentrations (µg/g)

Baseline Mean (SD) / End of Treatment Mean (SD)
AMR 101 4 g/day (n=49): 6.09 (2.248) / 43.28 (17.957)
AMR 101 2 g/day (n=49): 8.19 (2.741) / 28.38 (8.467)
Placebo (n=48): 7.09 (3.320) / 6.40 (3.313)

AA Plasma Concentrations (mcg/g)

Baseline (SD) / End of Treatment (SD)
AMR 101 4 g/day (n=49): 281.4 (71.0) / 222.8 (66.1)
AMR 101 2 g/day (n=51): 301.2 (73.5) / 266.7 (61.2)
Placebo (n=51): 307.6 (75.1) / 328.4 (67.8)

AA RBC Concentrations (mcg/g)

Baseline (SD) / End of Treatment (SD)
AMR 101 4 g/day (n=43): 184.7 (37.2) / 153.1 (28.8)
AMR 101 2g/day (n=48): 190.9 (28.6) / 173.0 (25.7)
Placebo (n=46): 190.3 (25.4) / 195.1 (25.9)